All Biotech News

List of articles in category All Biotech News
Title	Published Date
Noscendo Reaches CE Certification as Key Milestone for its Proprietary Diagnostic Platform DISQVER® and Conducts Successful Piloting in Eight Maximum Care Hospitals	09/10/2019
Mario Polywka Joins Orbit Discovery’s Board of Directors	08/30/2019
rfxcel, the Global Leader in Track and Trace Solutions, Continues Rapid Growth in Russia, Doubling the Size of Its Team, Entering New Industries	08/28/2019
Velabs Therapeutics Enters into a Screening Cooperation with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening After Successful Feasibility Study	08/27/2019
Vaccitech Appoints Bill Enright as New Chief Executive Officer	08/27/2019
rfxcel Will Exhibit at CPhI Middle East & Africa, the Largest Pharmaceutical Event in the Region	08/22/2019
denovoMATRIX Introduces Ready-To-Use, Chemically Defined Coated Cell Cultureware for Serum-Free hMSC Expansion	08/22/2019
Atelerix Consortium Awarded £267,000 Innovate UK Grant for Collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies	08/21/2019
HALIX Starts Operational Production with New cGMP Facility in Q4-2019	08/09/2019
Sartorius Stedim Biotech Launches New Services for Mammalian Cell Bank Manufacturing	08/08/2019
Cytena GmbH Announces That It Has Been Entered into an Agreement to Be Acquired by CELLINK	08/05/2019
Results of the Pivotal Phase 3 Study of the Bempedoic Acid / Ezetimibe Combination Tablet Published in the European Journal of Preventative Cardiology Demonstrated Significant LDL-C Lowering	07/31/2019
Cytena Founds Subsidiary in Taiwan	07/23/2019
SOTIO Initiates First-In-Human Clinical Trial with IL-15 Superagonist SO-C101	07/11/2019
Prestige BioPharma Releases Positive Results from Phase I Study of HD204, Biosimilar Candidate to Bevacizumab	07/08/2019
Prestige Biopharma and Pharmapark Announce License and Supply Agreement to Commercialize Prestige's Trastuzumab Biosimilar in the Russian Federation	07/08/2019
Confo Therapeutics and DyNAbind Announce Drug Discovery Collaboration to Identify Novel GPCR-Modulating Compounds	07/03/2019
New Biotage® VacMaster™ Disk - Vacuum Extraction with Rugged Versatility	06/28/2019
Velabs Therapeutics Announces €3 Million Series B Financing to Advance its Functional Antibody Screening Programme	06/27/2019
New ambr® 250 Modular Bioreactor Vessel Launched for Cell and Gene Therapy Applications	06/27/2019
MammaPrint® Becomes Only Molecular Diagnostic Recommended for Early-Stage Node-Positive Breast Cancer Patients in ASCO-Endorsed Cancer Care Ontario Guidelines	06/26/2019
Prestige BioPharma Reports Positive Top-Line Phase III Results for Tuznue® (Trastuzumab Biosimilar)	06/24/2019
Clinigen Broadens Partnership with Accord Healthcare to Supply and Distribute Cardioxane® and Savene® in Poland	06/24/2019
Agendia Announces Publication of Study Validating Use of MammaPrint and BluePrint Molecular Diagnostics using Targeted RNA Next-Generation Sequencing Technology	06/20/2019
Phase 2 Trial Shows Efficacy of CyTuVax’s Adjuvant Platform Technology	06/17/2019
Osteolabs GmbH Successfully Closes Seed Financing Round	06/17/2019
SAGA Raises 40 Million SEK (€3.7 Million) To Advance Ultrasensitive Cancer Liquid Biopsies	06/11/2019
arivis Presents the New Vision4D 3.1 Release for Working with Multi-Dimensional Big Image Data	06/05/2019
Strategic Collaboration between Biotage and Yingsheng on the Chinese Market for Clinical Mass Spectrometry Applications	06/04/2019
apceth Will Operate as the Commercial Manufacturer in Europe for Zynteglo™, bluebird bio’s Gene Therapy for β-Thalassemia	06/04/2019

Page 29 of 88